137 related articles for article (PubMed ID: 33877023)
1. Cardiac manifestations in Finnish gelsolin amyloidosis patients.
Mustonen T; Holkeri A; Holmström M; Atula S; Pakarinen S; Lehmonen L; Kiuru-Enari S; Aro AL
Amyloid; 2021 Sep; 28(3):168-172. PubMed ID: 33877023
[TBL] [Abstract][Full Text] [Related]
2. Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.
Schmidt EK; Mustonen T; Kiuru-Enari S; Kivelä TT; Atula S
Orphanet J Rare Dis; 2020 Jan; 15(1):19. PubMed ID: 31952544
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in the clinical course of Finnish gelsolin amyloidosis.
Atula S; Nikoskinen T; Saastamoinen A; Strbian D; Schmidt EK; Kiuru-Enari S
Amyloid; 2016; 23(1):33-8. PubMed ID: 26805765
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic features and need for pacemaker in cardiac amyloidosis: Analysis of 58 cases.
Pericet-Rodriguez C; López-Aguilera J; Durán-Torralba C; Castillo-Dominguez JC; Ruiz-Ortiz M; Perea-Armijo J; Delgado-Ortega M; Mesa-Rubio D; González-Manzanares R; Ruiz de Castroviejo J; Martín-Dorado E; Gallo-Fernández I; López-Baizán J; Pastor-Wulf D; Rodriguez-Almodovar A; Pan Álvarez-Osorio M; Anguita-Sánchez M
Med Clin (Barc); 2022 Jul; 159(2):78-84. PubMed ID: 35074177
[TBL] [Abstract][Full Text] [Related]
5. [Neurological manifestations of AGel amyloidosis (Meretoja's syndrome) in a German family].
Bürmann J; Fassbender K; Henn W; Lohse P; Holzhoffer C; Fassbender K; Dillmann U
Fortschr Neurol Psychiatr; 2011 Apr; 79(4):238-41. PubMed ID: 21480154
[TBL] [Abstract][Full Text] [Related]
6. Common origin of the gelsolin gene variant in 62 Finnish AGel amyloidosis families.
Mustonen T; Schmidt EK; Valori M; Tienari PJ; Atula S; Kiuru-Enari S
Eur J Hum Genet; 2018 Jan; 26(1):117-123. PubMed ID: 29167514
[TBL] [Abstract][Full Text] [Related]
7. Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions.
Mendelson L; Prokaeva T; Lau KHV; Sanchorawala V; McCausland K; Spencer B; Dasari S; McPhail ED; Kaku MC
Amyloid; 2023 Dec; 30(4):357-363. PubMed ID: 37140928
[TBL] [Abstract][Full Text] [Related]
8. Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.
Lehmonen L; Kaasalainen T; Atula S; Mustonen T; Holmström M
Int J Cardiovasc Imaging; 2019 Feb; 35(2):351-358. PubMed ID: 30848402
[TBL] [Abstract][Full Text] [Related]
9. Causes of death and life span in Finnish gelsolin amyloidosis.
Schmidt EK; Atula S; Tanskanen M; Nikoskinen T; Notkola IL; Kiuru-Enari S
Ann Med; 2016 Aug; 48(5):352-8. PubMed ID: 27137880
[TBL] [Abstract][Full Text] [Related]
10. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
11. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome.
Kivelä T; Tarkkanen A; Frangione B; Ghiso J; Haltia M
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3759-69. PubMed ID: 8088963
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
Donnellan E; Wazni OM; Saliba WI; Hanna M; Kanj M; Patel DR; Wilner B; Kochar A; Jaber WA
Am J Cardiol; 2020 Aug; 128():140-146. PubMed ID: 32650908
[TBL] [Abstract][Full Text] [Related]
13. Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.
Schmidt EK; Kiuru-Enari S; Atula S; Tanskanen M
Amyloid; 2019 Sep; 26(3):118-124. PubMed ID: 31122115
[No Abstract] [Full Text] [Related]
14. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.
Sano M; Satoh H; Suwa K; Nobuhara M; Saitoh T; Saotome M; Urushida T; Katoh H; Shimoyama K; Suzuki D; Ogawa N; Takehara Y; Sakahara H; Hayashi H
Heart Vessels; 2015 Nov; 30(6):779-88. PubMed ID: 24996373
[TBL] [Abstract][Full Text] [Related]
16. Hereditary gelsolin amyloidosis.
Kiuru-Enari S; Haltia M
Handb Clin Neurol; 2013; 115():659-81. PubMed ID: 23931809
[TBL] [Abstract][Full Text] [Related]
17. Cutis laxa in hereditary gelsolin amyloidosis.
Kiuru-Enari S; Keski-Oja J; Haltia M
Br J Dermatol; 2005 Feb; 152(2):250-7. PubMed ID: 15727635
[TBL] [Abstract][Full Text] [Related]
18. Right, but not left, bundle branch block is associated with large anteroseptal scar.
Strauss DG; Loring Z; Selvester RH; Gerstenblith G; Tomaselli G; Weiss RG; Wagner GS; Wu KC
J Am Coll Cardiol; 2013 Sep; 62(11):959-67. PubMed ID: 23707313
[TBL] [Abstract][Full Text] [Related]
19. The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients.
Ridolfi RL; Bulkley BH; Hutchins GM
Am J Med; 1977 May; 62(5):677-86. PubMed ID: 871125
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the ECG based Selvester scoring method to estimate myocardial scar burden and predict clinical outcome in patients with left bundle branch block, with comparison to late gadolinium enhancement CMR imaging.
Chaudhry U; Platonov PG; Jablonowski R; Couderc JP; Engblom H; Xia X; Wieslander B; Atwater BD; Strauss DG; Van der Pals J; Ugander M; Carlsson M; Borgquist R
Ann Noninvasive Electrocardiol; 2017 Sep; 22(5):. PubMed ID: 28248005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
